IFN-γ, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites

Scandinavian Journal of Immunology

Volumn 66, Issue 2-3, 2007, Pages 297-308

  Marinho, C R F ^a   Nunez Apaza L N ^a   Martins Santos, R ^a   Bastos, K R B ^a   Bombeiro, A L ^a   Bucci, D Z ^a   Sardinha, L R ^a   Lima, M R D ^a   Alvarez J M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHAGAS DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL INFECTION; HEART MUSCLE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION CONTROL; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PARALYSIS; PARASITE CONTROL; PARASITE VIRULENCE; PARASITEMIA; PHENOTYPE; PRIORITY JOURNAL; PROGRESSIVE PARALYSIS SYNDROME; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPINAL CORD LESION; TISSUE INJURY; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODY SPECIFICITY; CELL LINE; CHAGAS CARDIOMYOPATHY; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; NITRIC OXIDE; TRYPANOSOMA CRUZI; VIRULENCE;

EID: 34447336725     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01958.x     Document Type: Article

References (58)

1. Morel CM, Lazdins J. Chagas disease. Nat Rev Microbiol 2003 1 : 14 5.
2. Andrade SG, Andrade ZA. Pathology of prolonged experimental Chagas' disease. Rev Inst Med Trop Sao Paulo 1968 10 : 180 7.
3. Laguens RP, Meckert PC, Gelpi RJ. Chronic Chagas disease in the mouse. I. Electrocardiographic and morphological patterns of the cardiopathy. Medicina (B Aires) 1981 41 : 35 9.
4. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996 98 : 1709 12.
5. Engman DM, Leon JS. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 2002 81 : 123 32.
6. Pontes-de-Carvalho L, Santana CC, Soares MB, Oliveira GG, Cunha-Neto E, Ribeiro-dos-Santos R. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 2002 18 : 131 8.
7. Ribeiro Dos Santos R, Hudson L. Trypanosoma cruzi: immunological consequences of parasite modification of host cells. Clin Exp Immunol 1980 40 : 36 41.
8. Said G, Joskowicz M, Barreira AA, Eisen H. Neuropathy associated with experimental Chagas' disease. Ann Neurol 1985 18 : 676 83.
9. Palomino SA, Aiello VD, Higuchi ML. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 2000 94 : 571 9.
10. Tarleton RL. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 2001 31 : 550 4.
11. Vago AR, Macedo AM, Adad SJ, Reis DD, Correa-Oliveira R. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet 1996 348 : 891 2.
12. Zhang L, Tarleton RL. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis 1999 180 : 480 6.
13. Marinho CRF. A infecção murina pelo clone Sylvio X10/4 de Trypanosoma cruzi: um modelo para estudo da patogenia da doença de Chagas crônica. Doctorate Thesis, University of São Paulo : Departamento de Imunologia, 2003.
14. Anez N, Carrasco H, Parada H et al. Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg 1999 60 : 726 32.
15. Rocha A, de Meneses AC, da Silva AM et al. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 1994 50 : 261 8.
16. Sartori AM, Neto JE, Nunes EV et al. Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis 2002 186 : 872 5.
17. Sartori AM, Caiaffa-Filho HH, Bezerra RC, Do SGC, Lopes MH, Shikanai-Yasuda MA. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg 2002 67 : 521 3.
18. Russo M, Minoprio P, Coutinho A, Hontebeyrie-Joskowicz M. Depletion of L3T4+ T lymphocytes during acute Trypanosoma cruzi infection abolish macrophage and B lymphocyte activation but not tissue inflammatory reaction. Mem Inst Oswaldo Cruz 1988 83 : 527 38.
19. Araujo FG. Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) T lymphocytes. Infect Immun 1989 57 : 2246 8.
20. Rottenberg M, Cardoni RL, Andersson R, Segura EL, Orn A. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scand J Immunol 1988 28 : 573 82.
21. Rottenberg ME, Bakhiet M, Olsson T et al. Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun 1993 61 : 5129 33.
22. Rottenberg ME, Riarte A, Sporrong L et al. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Immunol Lett 1995 45 : 53 60.
23. Tarleton RL, Koller BH, Latour A, Postan M. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 1992 356 : 338 40.
24. Tarleton RL. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol 1990 144 : 717 24.
25. Rodriguez AM, Santoro F, Afchain D, Bazin H, Capron A. Trypanosoma cruzi infection in B-cell-deficient rats. Infect Immun 1981 31 : 524 9.
26. Cardillo F, Voltarelli JC, Reed SG, Silva JS. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun 1996 64 : 128 34.
27. Sardinha LR, Elias RM, Mosca T et al. Contribution of NK, NK T, gammadelta T, and alphabeta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect Immun 2006 74 : 2031 42.
28. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 1992 22 : 2501 6.
29. Munoz-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992 22 : 301 7.
30. Silva JS, Vespa GN, Cardoso MA, Aliberti JC, Cunha FQ. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 1995 63 : 4862 7.
31. Hunter CA, Slifer T, Araujo F. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infect Immun 1996 64 : 2381 6.
32. Silva JS, Aliberti JC, Martins GA, Souza MA, Souto JT, Padua MA. The role of IL-12 in experimental Trypanosoma cruzi infection. Braz J Med Biol Res 1998 31 : 111 5.
33. Aliberti JC, Cardoso MA, Martins GA, Gazzinelli RT, Vieira LQ, Silva JS. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 1996 64 : 1961 7.
34. Bastos KR, Marinho CR, Barboza R, Russo M, Alvarez JM, D'Imperio Lima MR. What kind of message does IL-12/IL-23 bring to macrophages and dendritic cells Microb Infect 2004 6 : 630 6.
35. Bastos KR, Alvarez JM, Marinho CR, Rizzo LV, Lima MR. Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile. J Leukoc Biol 2002 71 : 271 8.
36. Miyahira Y, Katae M, Kobayashi S et al. Critical contribution of CD28-CD80/CD86 costimulatory pathway to protection from Trypanosoma cruzi infection. Infect Immun 2003 71 : 3131 7.
37. Martins GA, Campanelli AP, Silva RB et al. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection. Microb Infect 2004 6 : 1133 44.
38. Postan M, Dvorak JA, McDaniel JP. Studies of Trypanosoma cruzi clones in inbred mice. I. A comparison of the course of infection of C3H/HEN- mice with two clones isolated from a common source. Am J Trop Med Hyg 1983 32 : 497 506.
39. Silveira F, Viana dias M, Pereira pardal P, Oliveira Lobao A, Britto Melo G. Nono caso autóctone de doença de Chagas registrado no estado do Pará, Brasil (Nota prévia). Hileia Medica, Belém 1979 1 : 61 2.
40. Starobinas N, Russo M, Minoprio P, Hontebeyrie-Joskowicz M. Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice Res Immunol 1991 142 : 117 22.
41. Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002 110 : 493 7.
42. Marinho CR, Bucci DZ, Dagli ML et al. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun 2004 72 : 2350 7.
43. Marinho CR, D'Imperio Lima MR, Grisotto MG, Alvarez JM. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 1999 67 : 308 18.
44. Marinho CR, Bastos KR, Sardinha LR, Grisotto MG, Lima MR, Alvarez JM. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. J Parasitol 2004 90 : 516 23.
45. Michailowsky V, Silva NM, Rocha CD, Vieira LQ, Lannes-Vieira J, Gazzinelli RT. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol 2001 159 : 1723 33.
46. Campos MA, Closel M, Valente EP et al. Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. J Immunol 2004 172 : 1711 8.
47. Cummings KL, Tarleton RL. Inducible nitric oxide synthase is not essential for control of Trypanosoma cruzi infection in mice. Infect Immun 2004 72 : 4081 9.
48. Holscher C, Kohler G, Muller U, Mossmann H, Schaub GA, Brombacher F. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 1998 66 : 1208 15.
49. Saeftel M, Fleischer B, Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun 2001 69 : 2252 9.
50. Petray P, Castanos-Velez E, Grinstein S, Orn A, Rottenberg ME. Role of nitric oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett 1995 47 : 121 6.
51. Schroder K, Lichtinger M, Irvine KM et al. PU.1 and ICSBP control constitutive and IFN-{gamma}-regulated Tlr9 gene expression in mouse macrophages. J Leukoc Biol 2007 14 : 14.
52. Sha Z, Compans RW. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol 2000 74 : 4999 5005.
53. Rahemtulla A, Kundig TM, Narendran A et al. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Eur J Immunol 1994 24 : 2213 8.
54. Kumar S, Tarleton RL. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 1998 20 : 207 16.
55. Nickell SP, Sharma D. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance. Exp Parasitol 2000 94 : 207 16.
56. Almeida-Leite CM, Galvao LM, Afonso LC, Cunha FQ, Arantes RM. Interferon-gamma induced nitric oxide mediates in vitro neuronal damage by Trypanosoma cruzi-infected macrophages. Neurobiol Dis 2007 25 : 170 8. Epub 20 October 2006.
57. Xu J, Drew PD. Peroxisome proliferator-activated receptor-gamma agonists suppress the production of IL-12 family cytokines by activated glia. J Immunol 2007 178 : 1904 13.
58. Elias RM, Sardinha LR, Bastos KR et al. Role of CD28 in polyclonal and specific T and B cell responses required for protection against blood stage malaria. J Immunol 2005 174 : 790 9.